A citation-based method for searching scientific literature

An-Hsun Chou, Si-Ying Chen, Tu-Hsueh Yeh, Yi-Hsin Weng, Hung-Li Wang. Neurobiol Dis 2011
Times Cited: 70



Daniel Goti, Scott M Katzen, Jesse Mez, Noam Kurtis, Jennifer Kiluk, Lea Ben-Haïem, Nancy A Jenkins, Neal G Copeland, Akira Kakizuka, Alan H Sharp, Christopher A Ross, Peter R Mouton, Veronica Colomer. J Neurosci 2004
Times Cited: 146




List of shared articles



Times cited

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.
A Matilla-Dueñas, T Ashizawa, A Brice, S Magri, K N McFarland, M Pandolfo, S M Pulst, O Riess, D C Rubinsztein, J Schmidt,[...]. Cerebellum 2014
84


Autosomal-dominant cerebellar ataxias.
Andrew Mundwiler, Vikram G Shakkottai. Handb Clin Neurol 2018
17


Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Carlos A Matos, Sandra de Macedo-Ribeiro, Ana Luísa Carvalho. Prog Neurobiol 2011
91

Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
Melvin M Evers, Lodewijk J A Toonen, Willeke M C van Roon-Mom. Mol Neurobiol 2014
50

Genetically engineered mouse models of the trinucleotide-repeat spinocerebellar ataxias.
Melissa A C Ingram, Harry T Orr, H Brent Clark. Brain Res Bull 2012
13

Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy.
Carlos A Matos, Luís Pereira de Almeida, Clévio Nóbrega. J Neurochem 2019
50

Mouse models of polyglutamine diseases: review and data table. Part I.
Maciej Figiel, Wojciech J Szlachcic, Pawel M Switonski, Agnieszka Gabka, Wlodzimierz J Krzyzosiak. Mol Neurobiol 2012
37


Animal Models of Machado-Joseph Disease.
Jana Schmidt, Thorsten Schmidt. Adv Exp Med Biol 2018
0

From pathways to targets: understanding the mechanisms behind polyglutamine disease.
Jonasz Jeremiasz Weber, Anna Sergeevna Sowa, Tina Binder, Jeannette Hübener. Biomed Res Int 2014
37

Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease).
Veronica F Colomer Gould. Neurotherapeutics 2012
24

Clinical neurogenetics: autosomal dominant spinocerebellar ataxia.
Vikram G Shakkottai, Brent L Fogel. Neurol Clin 2013
49

Toward understanding Machado-Joseph disease.
Maria do Carmo Costa, Henry L Paulson. Prog Neurobiol 2012
163

Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.
Sofia Esteves, Sara Duarte-Silva, Patrícia Maciel. Med Res Rev 2017
13

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
54

Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
Nélio Gonçalves, Ana T Simões, Rodrigo A Cunha, Luís Pereira de Almeida. Ann Neurol 2013
55

Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.
Carlos A Matos, Luis Pereira de Almeida, Clevio Nobrega. Curr Pharm Des 2017
17